BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10811608)

  • 1. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.
    Müller D; Thieke K; Bürgin A; Dickmanns A; Eilers M
    EMBO J; 2000 May; 19(10):2168-80. PubMed ID: 10811608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M; Tiihonen E; Heiskanen A; Laiho M
    Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p27(Kip1) in human intestinal cell differentiation.
    Deschênes C; Vézina A; Beaulieu JF; Rivard N
    Gastroenterology; 2001 Feb; 120(2):423-38. PubMed ID: 11159883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
    Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
    Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
    Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
    J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity.
    McArthur GA; Foley KP; Fero ML; Walkley CR; Deans AJ; Roberts JM; Eisenman RN
    Mol Cell Biol; 2002 May; 22(9):3014-23. PubMed ID: 11940659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.
    Swanson C; Ross J; Jackson PK
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7796-801. PubMed ID: 10884410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
    Müller D; Bouchard C; Rudolph B; Steiner P; Stuckmann I; Saffrich R; Ansorge W; Huttner W; Eilers M
    Oncogene; 1997 Nov; 15(21):2561-76. PubMed ID: 9399644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
    Wang G; Miskimins R; Miskimins WK
    Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
    Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
    Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation.
    Xu X; Nakano T; Wick S; Dubay M; Brizuela L
    Biochemistry; 1999 Jul; 38(27):8713-22. PubMed ID: 10393546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
    Mann DJ; Child ES; Swanton C; Laman H; Jones N
    EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27Kip1 regulates T cell proliferation.
    Mohapatra S; Agrawal D; Pledger WJ
    J Biol Chem; 2001 Jun; 276(24):21976-83. PubMed ID: 11297537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.